These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8214357)

  • 1. Tumor necrosis factor-alpha in malignant disease.
    Abrahamsson J; Carlsson B; Mellander L
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):364-9. PubMed ID: 8214357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor in children with malignancies.
    Saarinen UM; Koskelo EK; Teppo AM; Siimes MA
    Cancer Res; 1990 Feb; 50(3):592-5. PubMed ID: 2297700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.
    Ohga S; Matsuzaki A; Nishizaki M; Nagashima T; Kai T; Suda M; Ueda K
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):291-8. PubMed ID: 8328642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
    Girardin E; Grau GE; Dayer JM; Roux-Lombard P; Lambert PH
    N Engl J Med; 1988 Aug; 319(7):397-400. PubMed ID: 3135497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis.
    Alecu M; Geleriu L; Coman G; Gălăţescu L
    Rom J Intern Med; 1998; 36(3-4):251-9. PubMed ID: 10822522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-1 and tumor necrosis factor activities in febrile children with acute leukemia.
    Ishii E; Ohga S; Ueda K; Akazawa K
    Int J Hematol; 1991 Feb; 54(1):79-84. PubMed ID: 1954355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis.
    Gomi T; Shiohara T; Munakata T; Imanishi K; Nagashima M
    Arch Dermatol; 1991 Jun; 127(6):827-30. PubMed ID: 1903629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
    Närkiö-Mäkelä M; Teppo AM; Meri S
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
    Saxena N; Aggarwal A; Misra R
    J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
    Sun A; Wang JT; Chia JS; Chiang CP
    J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions].
    Matsubara T
    Arerugi; 1990 Feb; 39(2 Pt 1):118-23. PubMed ID: 2112909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
    Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.
    Villinger F; Rollin PE; Brar SS; Chikkala NF; Winter J; Sundstrom JB; Zaki SR; Swanepoel R; Ansari AA; Peters CJ
    J Infect Dis; 1999 Feb; 179 Suppl 1():S188-91. PubMed ID: 9988183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
    Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
    Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes.
    Alexandrakis M; Coulocheri S; Xylouri I; Ganotakis E; Eliakis P; Karkavitsas N; Eliopoulos GD
    Haematologia (Budap); 1998; 29(1):13-24. PubMed ID: 9704253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.